JP2014530242A5 - - Google Patents

Download PDF

Info

Publication number
JP2014530242A5
JP2014530242A5 JP2014535953A JP2014535953A JP2014530242A5 JP 2014530242 A5 JP2014530242 A5 JP 2014530242A5 JP 2014535953 A JP2014535953 A JP 2014535953A JP 2014535953 A JP2014535953 A JP 2014535953A JP 2014530242 A5 JP2014530242 A5 JP 2014530242A5
Authority
JP
Japan
Prior art keywords
topical formulation
formulation according
ointment
topical
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014535953A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014530242A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014530242A publication Critical patent/JP2014530242A/ja
Publication of JP2014530242A5 publication Critical patent/JP2014530242A5/ja
Pending legal-status Critical Current

Links

JP2014535953A 2011-10-13 2012-10-12 皮膚疾病の処置用のケメリンc15ペプチドの局所製剤 Pending JP2014530242A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161546833P 2011-10-13 2011-10-13
US61/546,833 2011-10-13

Publications (2)

Publication Number Publication Date
JP2014530242A JP2014530242A (ja) 2014-11-17
JP2014530242A5 true JP2014530242A5 (enExample) 2015-12-03

Family

ID=48082531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014535953A Pending JP2014530242A (ja) 2011-10-13 2012-10-12 皮膚疾病の処置用のケメリンc15ペプチドの局所製剤

Country Status (8)

Country Link
US (2) US20140349943A1 (enExample)
EP (1) EP2766032A4 (enExample)
JP (1) JP2014530242A (enExample)
CN (1) CN104159594A (enExample)
AU (1) AU2012323952A1 (enExample)
CA (1) CA2851643A1 (enExample)
HK (1) HK1202064A1 (enExample)
WO (1) WO2013056147A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2782015C (en) 2009-12-11 2020-08-25 Neuron Systems, Inc. Topical ophthalmic compositions and methods for the treatment of macular degeneration
CN111135171B (zh) 2013-01-23 2023-09-08 奥尔德拉医疗公司 与毒性醛相关的疾病和治疗
WO2014168721A2 (en) 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
CN103432073A (zh) * 2013-09-11 2013-12-11 中国药科大学 一种肿瘤靶向纳米制剂及其制备方法
WO2015153838A1 (en) * 2014-04-02 2015-10-08 Rogne Bioscience Inc. Methods and compositions for treating inflammatory disorders
JP6719181B2 (ja) * 2015-07-16 2020-07-08 花王株式会社 皮膚化粧料
CN118724806A (zh) 2015-08-21 2024-10-01 奥尔德拉医疗公司 氘化化合物和其用途
CN105277194B (zh) * 2015-10-12 2019-01-08 南京信息工程大学 一种基于云平台的室内交互式引导实现方法
ES2805037T3 (es) * 2016-01-22 2021-02-10 Tufts Medical Ct Inc Compuestos y métodos para tratar la inflamación
HUE054241T2 (hu) * 2016-03-28 2021-08-30 Vidac Pharma Ltd Stabil gyógyszerkészítmények topikális beadásra és alkalmazásuk
CN111356451A (zh) 2017-10-10 2020-06-30 奥尔德拉医疗公司 炎性病症的治疗
CN108192866B (zh) * 2018-03-07 2021-05-11 郑州大学第一附属医院 Sfn联合il-15和il-21制备记忆性t细胞的方法及应用
US20200038392A1 (en) * 2018-08-03 2020-02-06 Aldeyra Therapeutics, Inc. Topical compositions and methods of preparation and use
CN112714762A (zh) 2018-08-06 2021-04-27 奥尔德拉医疗公司 多晶型化合物及其用途
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
US12144794B2 (en) * 2019-03-06 2024-11-19 Isdin, S.A. Use of caprylic and capric triglycerides for the treatment of a disease or condition mediated by filaggrin or collagen deficiency
US11730705B2 (en) 2019-05-02 2023-08-22 The Board Of Trustees Of The Leland Stanford Junior University Small molecule CMKLR1 antagonists in inflammatory disease
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CN113784954A (zh) 2019-05-02 2021-12-10 奥尔德拉医疗公司 多晶型化合物和其用途
CA3164165A1 (en) * 2020-01-10 2021-07-15 Robert Bruce Register Topical compositions containing rofecoxib and methods of making and using the same
WO2021231792A1 (en) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
JP2023537111A (ja) * 2020-08-12 2023-08-30 バイエル・アクチエンゲゼルシヤフト 環状ケメリン-9誘導体
CA3191359A1 (en) * 2020-09-08 2022-03-17 John D. O'neill Tissue-derived matrikine compositions and methods therefor
CN112190687B (zh) * 2020-11-19 2022-06-10 温州医科大学附属第一医院 一种用于减少皮肤创伤瘢痕的药物及其应用
CN112881668B (zh) * 2021-01-18 2022-04-12 江苏省中医院 两种血清代谢物单独或联合用于制备诊断干燥综合征的试剂盒的用途
US20240197619A1 (en) * 2022-12-14 2024-06-20 Alicia Marie Santino Turnbull Ointment or Balm and Method for Producing Same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419658B2 (en) * 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
AU2003274076A1 (en) * 2002-10-31 2004-05-25 Ipf Pharmaceuticals Gmbh Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases
GB0705488D0 (en) * 2007-03-22 2007-05-02 Isis Innovation Treatment of inflammation and/or endotoxic shock
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
AU2009246333B2 (en) * 2008-05-16 2013-05-09 Corthera, Inc. Method of promoting wound healing
KR101559068B1 (ko) * 2008-08-27 2015-10-20 (주)아모레퍼시픽 키메린을 함유하는 지방세포 분화 억제 및 지방세포 내의 지질체 수준 감소용 조성물
US20100092546A1 (en) * 2008-10-10 2010-04-15 Gurtner Geoffrey C Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds

Similar Documents

Publication Publication Date Title
AR124134A2 (es) Formulación de uso tópico para un inhibidor de jak
CL2019002172A1 (es) Agente terapéutico para enfermedades del hígado.
JP2015522049A5 (enExample)
WO2009053741A3 (en) Novel formulation
JP2013515002A5 (enExample)
JP2011529038A5 (enExample)
AR070047A1 (es) Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog.
AR090349A1 (es) Terapia de combinacion para trastornos proliferativos, kit y uso
JP2012531448A5 (enExample)
JP2019524774A5 (enExample)
JP2002526407A5 (enExample)
WO2013022243A3 (ko) 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
JP2018528259A5 (enExample)
JP2013520448A5 (enExample)
JP2010510194A5 (enExample)
RU2012149868A (ru) Полисахарид семян для применения в лечении воспалительных заболеваний
JP2012525358A5 (enExample)
JP2016538288A5 (enExample)
WO2016181355A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
JP2016510332A5 (enExample)
RU2019102890A (ru) Фармацевтические композиции, содержащие флурбипрофен
RU2013142445A (ru) Фармацевтический препарат для местного применения, содержащий в-220
NZ606177A (en) Compositions for the treatment of actinic keratosis
CO6241114A2 (es) Composicion farmaceutica que comprende la combinacion del agente antimicrobiano ciprofloxacino y el agente antioxidante acido ascorbico para el tratamiento de infecciones urinarias
RU2017105074A (ru) Комбинация адапалена и бензоилпероксида для лечения тяжелой формы акне